Non-clinical pharmacy managers in England could come under the scope of regulation proposals launched by the Department of Health and Social Care (DHSC).
Its public consultation sets out measures that aim to increase accountability of NHS managers and leaders, and set ‘clear and consistent’ professional standards, including a potential regulatory system.
The DHSC has confirmed to The Pharmacist that if responses relating to non-clinical managers in settings such as community pharmacy and general practice are raised during its consultation process, these will be taken into account.
The consultation includes questions on the scope of managers and organisations a system of regulation should apply to.
And DHSC confirmed that it will carefully consider all responses to the consultation, which will inform future policy decisions.
A spokesperson for the Pharmacists' Defence Association (PDA) told The Pharmacist that reform to address the regulation of non-clinical managers was 'long overdue'.
'Through our casework we often see the “consequence-free influence” of non-clinical managers on patient care and the wider operation of pharmacy, both in NHS employers and in contractor organisations such as GP practices and community pharmacy,' they said.
'We welcome the consultation that has been recently launched, however there is a significant risk that such proposals could still fail to adequately protect patients if the regulation of managers at companies and businesses that provide NHS and private healthcare services to patients were excluded from any future changes.
'The PDA believes that the reforms would need to be broad to ensure that they encapsulate all “managers” influencing healthcare provision, not just those directly employed by the NHS,' the spokesperson added.
And they said the PDA would be submitting a response to the government's consultation.
In the wake of the Lucy Letby inquiry, the PDA raised ‘significant concerns’ about the power of non-clinical managers in community pharmacies, especially those operated by large private companies.
It said then that it ‘routinely’ receives reports about managers overruling the clinical judgement of registered pharmacists, potentially impacting patient safety.
The GPhC has also confirmed to The Pharmacist that it is currently reviewing the proposals in the consultation and will be making a written submission in due course.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.